In addition to weight management, GLP-1 drugs like Wegovy and Zepbound also help in controlling high blood sugar in people with type 2 diabetes by stimulating insulin release from the pancreas
[37] [38] See also [edit source] Dipeptidyl peptidase-4 Gastric inhibitory polypeptide GLP-1 receptor agonistsalbiglutide, dulaglutide, exenatide, liraglutide, lixisenatide, tirzepatide, and semaglutide, the last of which is marketed under the brands Ozempic, Rybelsus, and Wegovy
Patients should not assume that a product is safe because it appears on a polished website or is promoted in fitness, longevity, or peptide communities
These reports are uncommon and often involve patients with pre-existing liver conditions, concurrent medications, or other confounding factors
Thats why we always recommend pairing GLP-1 support with strength training even just a few short sessions a week can make a big difference
Exendin-4 administration did not modify S6K activity in the LH of lean and obese rats after four hours of re-feeding, whereas exendin-4 reduced S6K activity in the VMH of lean Zucker rats but not in their obese counterparts [83]